GASTRO-OESOPHAGEAL CANCER

Clinical trials for GASTRO-OESOPHAGEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTRO-OESOPHAGEAL CANCER trials appear

Sign up with your email to follow new studies for GASTRO-OESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo aims to outperform chemo in Tough-to-Treat stomach cancer

Disease control Completed

This phase 3 trial tested whether a combination of two drugs, regorafenib and nivolumab, helps people with advanced gastro-oesophageal cancer live longer than standard chemotherapy. The study included 462 adults whose cancer had stopped responding to prior treatments. The goal wa…

Matched conditions: GASTRO-OESOPHAGEAL CANCER

Phase: PHASE3 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

GASTRO-OESOPHAGEAL CANCER

Get alerted when new GASTRO-OESOPHAGEAL CANCER trials appear

New drug combo aims to outperform chemo in Tough-to-Treat stomach cancer